Roivant Sciences Raises $1.1 Billion in Equity Investment Led by SoftBank Vision Fund


Roivant focuses on developing and commercializing novel therapies through subsidiary Vants . These include Axovant (neurology), Myovant (women s health and endocrine diseases), Dermavant (dermatology), Enzyvant (rare diseases), and Urovant (urology). Datavant, a new technology-focused subsidiary, will be the first company in the Roivant family to operate outside of traditional biopharmaceutical development. Datavant aims to dissolve barriers [ ] The post Roivant Sciences Raises $1.1 Billion in Equity Investment Led by SoftBank Vision Fund appeared first on STL News.
http://bit.ly/2uoWcAh

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Create a website or blog at WordPress.com

Up ↑

%d bloggers like this: